Losartan Potassium Tablet, Film Coated
Product Images NDC 50090-7888

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 50090-7888). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907888)

Losartan Potassium 25 mg film coated tablets package label by A-S Medication Solutions. The label shows 90 tablets in the package, with storage instructions to keep at 68 to 77 degrees Fahrenheit and to protect from light. The NDC is 50090-7888-0. The label includes a lot number and standard regulatory text.*

FDA Label Image

Losartancamberlogo (Losartancamberlogo)

FDA Label Image

Losartanfigure1 (Losartanfigure1)

A line graph comparing the percentage of patients with a primary endpoint over study months for Atenolol and Losartan Potassium. The x-axis represents study months (0 to 66), and the y-axis represents the percentage of patients with the primary endpoint (0 to 16%). Two lines show the progression for each drug, with Atenolol as a dashed line and Losartan Potassium as a solid line, indicating a 13% adjusted risk reduction (p=0.021) for Losartan Potassium.*

FDA Label Image

Losartanfigure2 (Losartanfigure2)

A line graph comparing the percentage of patients with fatal or non-fatal stroke over a 66-month study period between Atenolol and Losartan potassium. The horizontal axis shows study months from 0 to 66, and the vertical axis shows the percentage of patients from 0 to 8%. The graph includes an annotation of adjusted risk reduction of 25% with a p-value of 0.001 favoring Losartan potassium.*

FDA Label Image

Losartanfigure3 (Losartanfigure3)

A clinical study forest plot comparing Losartan Potassium and Atenolol event rates and hazard ratios for primary composite outcomes and fatal/non-fatal stroke. The chart categorizes data by age, gender, race, ISH, diabetes status, and history of cardiovascular disease, showing hazard ratios with 95% confidence intervals for each subgroup.*

FDA Label Image

Losartanfigure4 (Losartanfigure4)

A line graph comparing the percentage of patients with an event over 48 months for Losartan Potassium and placebo groups. The y-axis shows the percentage of patients, and the x-axis indicates time in months. The solid line represents Losartan Potassium, and the dashed line represents placebo. Text on the graph notes a risk reduction of 16.1% and a p-value of 0.022.*

FDA Label Image

Losartanstructure (Losartanstructure)

Chemical structure diagram of Losartan Potassium showing the molecular arrangement including chlorine, hydroxyl group, butyl side chain, phenyl rings, triazole ring, and potassium ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.